Screening for minor changes in the distal part of the human dystrophin gene in Greek DMD/BMD patients

被引:0
|
作者
Kiriaki Kekou
Ariadni Mavrou
Lina Florentin
Sotiris Youroukos
Dimitrios I Zafiriou
Helen N Skouteli
Catherine Metaxotou
机构
[1] Genetic Unit,First Department of Pediatrics
[2] Athens University,undefined
[3] ‘Aghia Sophia’ Children's Hospital,undefined
来源
关键词
dystrophin gene; distal part; point mutations; mental retardation;
D O I
暂无
中图分类号
学科分类号
摘要
The distal part of the human dystrophin gene is characterised by particular features and seems to play an important functional role. Additionally in recent years several data have implicated minor mutations in this gene region in some patients with mental retardation (MR). In order to screen for pathogenic mutations at the distal part of the human dystrophin gene we have used single-strand conformation analysis of products amplified by polymerase chain reaction (PCR-SSCA) in 35 unrelated male Greek DMD/BMD patients with no detectable deletions. Seven patients also had severe mental retardation. Direct sequencing of samples demonstrating a shift of SSCA mobility revealed six different and pathogenic minor changes, five in DMD and one in a BMD patient. Four of the mutations were found in DMD patients with severe MR. Three of these mutations were localised in exon 66, which presents an interesting similarity with part of the 3′ end of the genome of eastern equine encephalomyelitis virus (EEEV). The present data from Greek DMD/BMD patients give further information about the phenotypic effects consequent on mutations in exons at the distal part of the human dystrophin gene.
引用
收藏
页码:179 / 187
页数:8
相关论文
共 50 条
  • [41] The spectrum of deletions and duplications in the dystrophin (DMD) gene in a cohort of patients with Duchenne muscular dystrophy in Sri Lanka
    Thakur, Nilam
    Abeysekera, Gayan
    Wanigasinghe, Jithangi
    Dissanayake, Vajira H. W.
    NEUROLOGY INDIA, 2019, 67 (03) : 714 - 716
  • [42] Novel mutations of dystrophin gene in DMD patients detected by rapid scanning in biplex exons DHPLC analysis
    Muscarella, Lucia Anna
    Piemontese, Maria Rosaria
    Barbano, Raffaela
    Fazio, Antonina
    Guarnieri, Vito
    Quattrone, Alessandro
    Zelante, Leopoldo
    BIOMOLECULAR ENGINEERING, 2007, 24 (02): : 231 - 236
  • [43] SARCOLEMMAL EXPRESSION OF DYSTROPHIN C-TERMINUS BUT REDUCED EXPRESSION OF 6Q-DYSTROPHIN-RELATED PROTEIN IN 2 DMD PATIENTS WITH LARGE DELETIONS OF THE DYSTROPHIN GENE
    BITTNER, RE
    SHORNY, S
    FERLINGS, R
    SPERL, W
    KRESS, W
    MULLER, CR
    CREMER, M
    LEGER, JJ
    VOIT, T
    NEUROMUSCULAR DISORDERS, 1995, 5 (02) : 81 - 92
  • [44] MLPA followed by target-NGS to detect mutations in the dystrophin gene of Peruvian patients suspected of DMD/DMB
    Guevara-Fujita, Maria Luisa
    Huaman-Dianderas, Francia
    Obispo, Daisy
    Sanchez, Rodrigo
    Barrenechea, Victor
    Rojas-Malaga, Diana
    Estrada-Cuzcano, Alejandro
    Trubnykova, Milana
    Cornejo-Olivas, Mario
    Marca, Victoria
    Gallardo, Bertha
    Duenas-Roque, Milagros
    Protzel, Ana
    Castaneda, Carlos
    Abarca, Hugo
    Celis, Luis
    La Serna-Infantes, Jorge
    Fujita, Ricardo
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2021, 9 (09):
  • [45] Deletion mutation analysis of dystrophin gene in Vietnamese DMD patients - identification of female carriers in their families by capillary electrophoresis
    Tran, K. V.
    Nguyen, S. T. B.
    Tran, T. H.
    Nguyen, H. T.
    Vu, D. C.
    Ta, V. T.
    Matsuo, M.
    NEUROMUSCULAR DISORDERS, 2010, 20 (9-10) : 659 - 659
  • [46] ARCUS-Mediated Excision of the "Hot Spot" Region of the Human Dystrophin Gene for the Treatment of Duchenne Muscular Dystrophy (DMD)
    Lewis, Whitney
    Owens, Gary
    Jordan-Steele, Matthew
    Heard, Nicole W.
    Morris, Benjamin
    Manzon, Emily
    Wang, Cheng-Wei
    Reddick, Traci
    Holt, Jason
    Morris, Dave C.
    Khairallah, Ramzi J.
    Ward, Christopher W.
    Martin, Jennifer
    Gorsuch, Cassie
    Shelton, Kelly
    Martin, Daniel
    Smith, Amy Rhoden
    Smith, Jeff
    Jantz, Derek
    MOLECULAR THERAPY, 2023, 31 (05) : 5 - 5
  • [47] Systemic Gene Therapy for DMD - Advanced Preclinical/Translational Studies To Minimize Risk and Maximize Potential Benefit for Patients With Dystrophin Gene Deletions
    Malik, Alock
    Mead, Andrew
    Petrov, Mihail
    VanBelzen, Daniel
    Song, Yafeng
    Lu, Xiangping
    Choi, Margaret
    Kornegay, Joe
    Stedman, Hansell
    MOLECULAR THERAPY, 2014, 22 : S236 - S237
  • [48] Intronic Alternative Polyadenylation in the Middle of the DMD Gene Produces Half-Size N-Terminal Dystrophin with a Potential Implication of ECG Abnormalities of DMD Patients
    Rani, Abdul Qawee Mahyoob
    Yamamoto, Tetsushi
    Kawaguchi, Tatsuya
    Maeta, Kazuhiro
    Awano, Hiroyuki
    Nishio, Hisahide
    Matsuo, Masafumi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [49] Stop codons, duplications and deletions off the dystrophin gene: Frequency and clinical follow-up in 201 DMD patients
    Magri, Francesca
    Del Bo, Roberto
    Ghezzi, Serena
    Tedeschi, Silvana
    D'Angelo, Maria Grazia
    Coviello, Domenico
    Prelle, Alessandro
    Bordoni, Andreina
    Sciacco, Monica
    Lamperti, Costanza
    Corti, Stefania
    Torrente, Yuan
    Moggio, Maurizio
    Bresolin, Nereo
    Comi, Giacomo P.
    NEUROLOGY, 2008, 70 (11) : A312 - A312
  • [50] Exon Skipping and Gene Transfer Restore Dystrophin Expression in Human Induced Pluripotent Stem Cells-Cardiomyocytes Harboring DMD Mutations
    Dick, Emily
    Kalra, Spandan
    Anderson, David
    George, Vinoj
    Ritso, Morten
    Laval, Steven H.
    Barresi, Rita
    Aartsma-Rus, Annemieke
    Lochmueller, Hanns
    Denning, Chris
    STEM CELLS AND DEVELOPMENT, 2013, 22 (20) : 2714 - 2724